Stock listing

ADOC Stock Price, News, Filings & Events — Adocia Sa

Selected listing: ADOC · EURONEXT · EUR · FR

This page tracks Adocia Sa's ADOC:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ADOC:EURONEXT. ADOC:EURONEXT is the stock-level entry point for investors researching Adocia Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Adocia SA is a public company listed on the French market under the ticker ADOC, with a market capitalization of approximately €87 million. The company focuses on developing innovative therapeutic solutions in the field of diabetes and other metabolic diseases. Adocia aims to enhance treatment options through its advanced drug delivery technologies.

ADOC:EURONEXTEURFRUpdated September 12, 2026
Adocia Sa logo
Ticker
ADOC:EURONEXT
Asset type
Stock
Market cap
$89.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
EURONEXT
Currency
EUR

Adocia Sa ADOC:EURONEXT stock context

This page tracks Adocia Sa's ADOC:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ADOC:EURONEXT. ADOC:EURONEXT is the stock-level entry point for investors researching Adocia Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Adocia SA is a public company listed on the French market under the ticker ADOC, with a market capitalization of approximately €87 million. The company focuses on developing innovative therapeutic solutions in the field of diabetes and other metabolic diseases. Adocia aims to enhance treatment options through its advanced drug delivery technologies.

Latest news from Adocia Sa

All Adocia Sa news →

Research Adocia Sa

Alternate listings